236 related articles for article (PubMed ID: 7520650)
1. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
[TBL] [Abstract][Full Text] [Related]
2. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
[TBL] [Abstract][Full Text] [Related]
3. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
4. [The safety of a new chemical typhoid preparation containing a complex of Vi and K antigens in tests of its acute and chronic toxicity].
Kharitonova AM; Grigor'eva LV; Bykovskaia SI; Ageeva VA; Stepanova LK; Belaia IuA
Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):57-60. PubMed ID: 1481607
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of purified Vi polysaccharide typhoid vaccine.
Park JH; Hong JJ; Choi ES; Lee JW; Park JH
J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
[TBL] [Abstract][Full Text] [Related]
6. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
7. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
Hall CB
Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
[No Abstract] [Full Text] [Related]
8. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
[TBL] [Abstract][Full Text] [Related]
9. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
10. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
Tacket CO; Levine MM; Robbins JB
Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615
[TBL] [Abstract][Full Text] [Related]
11. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
Robbins JD; Robbins JB
J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
Wang JY; Noriega FR; Galen JE; Barry E; Levine MM
Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868
[TBL] [Abstract][Full Text] [Related]
13. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB
Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460
[TBL] [Abstract][Full Text] [Related]
14. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
15. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
Gekker VD; Sergeeva NS
Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
[No Abstract] [Full Text] [Related]
16. Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
An SJ; Scaria PV; Chen B; Barnafo E; Muratova O; Anderson C; Lambert L; Chae MH; Yang JS; Duffy PE
Vaccine; 2018 May; 36(21):2978-2984. PubMed ID: 29681410
[TBL] [Abstract][Full Text] [Related]
17. Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
Ahmadi H; Tabaraie B; Maleknia S; Shapouri R; Nejati M; Pour Mirza Gholi F; Hedayati M; Sadati M; Zahednia S; Sharifat Salmani A
J Med Microbiol; 2013 Feb; 62(Pt 2):283-286. PubMed ID: 23105026
[TBL] [Abstract][Full Text] [Related]
18. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
Arya SC
Vaccine; 1997 Feb; 15(2):244. PubMed ID: 9066045
[No Abstract] [Full Text] [Related]
20. [Comparative study of autoantibody formation following immunization with different types of typhoid vaccines].
Negina IuP
Zh Mikrobiol Epidemiol Immunobiol; 1980 May; (5):69-72. PubMed ID: 7415680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
